The long-lasting improvement of sexual dysfunction in patients
with advanced, fluctuating Parkinson's disease induced by
pergolide: evidence from the results of an open, prospective,
one-year trial

J 2005

The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial

POHANKA, Michal; Petr KAŇOVSKÝ; Martin BAREŠ; Jiří PULKRÁBEK; Ivan REKTOR et. al.

Základní údaje

Originální název

The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial

Název česky

Dlouhodobé zlepšení sexuální dysfunkce u pacientů s pokročilou Parkinsonovou nemocí navozené podáváním pergolidu

Autoři

POHANKA, Michal (203 Česká republika); Petr KAŇOVSKÝ (203 Česká republika, garant); Martin BAREŠ (203 Česká republika); Jiří PULKRÁBEK (203 Česká republika) a Ivan REKTOR (203 Česká republika)

Vydání

Parkinsonism and Related Disorders, Oxford, Elsevier, 2005, 1353-8020

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.527

Kód RIV

RIV/00216224:14110/05:00031905

Organizační jednotka

Lékařská fakulta

UT WoS

000233791000006

Klíčová slova anglicky

Parkinson disease; pergolid; sexual dysfunction

Štítky

Parkinson disease, pergolid, sexual dysfunction

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 31. 3. 2010 23:28, prof. MUDr. Martin Bareš, Ph.D.

Anotace

ORIG CZ

V originále

Fourteen male patients suffering from Parkinson's disease, each of whom had been treated with L-DOPA, and in whom additional treatment with oral dopamine agonist (DA) was needed, were followed for a period of one year. Pergolide mesylate was given to each patient, and titrated to a total daily dose of 3 mg. All of the patients were taking L-DOPA. The assessments consisted of neurological examination, unified Parkinson's disease rating scale (UPDRS) III and IV subscales scoring, mini mental state examination (MMSE) scoring, the neuropsychological examination, biochemical and hematological examinations and a sexological examination during which the patients filled-in the international index of erectile function (IIEF) questionnaire. Pergolide mesylate significantly improved all sexual functions in younger male Parkinsonian patients who were still interested in sexual activities.

Česky

Dlouhodobé zlepšení sexuální dysfunkce u pacientů s pokročilou Parkinsonovou nemocí navozené podáváním pergolidu.

Návaznosti

MSM0021622404, záměr

Název: Vnitřní organizace a neurobiologické mechanismy funkčních systémů CNS

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Vnitřní organizace a neurobiologické mechanismy funkčních systémů CNS

Citovat

POHANKA, Michal; Petr KAŇOVSKÝ; Martin BAREŠ; Jiří PULKRÁBEK a Ivan REKTOR. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Parkinsonism and Related Disorders. Oxford: Elsevier, 2005, roč. 11, č. 8, s. 509-512. ISSN 1353-8020.

@article{711902,
   author = {Pohanka, Michal and Kaňovský, Petr and Bareš, Martin and Pulkrábek, Jiří and Rektor, Ivan},
   article_location = {Oxford},
   article_number = {8},
   keywords = {Parkinson disease; pergolid; sexual dysfunction},
   language = {eng},
   issn = {1353-8020},
   journal = {Parkinsonism and Related Disorders},
   title = {The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial},
   volume = {11},
   year = {2005}
}

TY  - JOUR
ID  - 711902
AU  - Pohanka, Michal - Kaňovský, Petr - Bareš, Martin - Pulkrábek, Jiří - Rektor, Ivan
PY  - 2005
TI  - The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial
JF  - Parkinsonism and Related Disorders
VL  - 11
IS  - 8
SP  - 509-512
EP  - 509-512
PB  - Elsevier
SN  - 13538020
KW  - Parkinson disease
KW  - pergolid
KW  - sexual dysfunction
N2  - Fourteen male patients suffering from Parkinson's disease, each of whom had been treated with L-DOPA, and in whom additional treatment with oral dopamine agonist (DA) was needed, were followed for a period of one year. Pergolide mesylate was given to each patient, and titrated to a total daily dose of 3 mg. All of the patients were taking L-DOPA. The assessments consisted of neurological examination, unified Parkinson's disease rating scale (UPDRS) III and IV subscales scoring, mini mental state examination (MMSE) scoring, the neuropsychological examination, biochemical and hematological examinations and a sexological examination during which the patients filled-in the international index of erectile function (IIEF) questionnaire. Pergolide mesylate significantly improved all sexual functions in younger male Parkinsonian patients who were still interested in sexual activities.
ER  -

POHANKA, Michal; Petr KAŇOVSKÝ; Martin BAREŠ; Jiří PULKRÁBEK a Ivan REKTOR. The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. \textit{Parkinsonism and Related Disorders}. Oxford: Elsevier, 2005, roč.~11, č.~8, s.~509-512. ISSN~1353-8020.

Přehled o publikaci